Skip to main content

Table 4 Visual outcome

From: Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy—a 5-year study from Singapore

Number of affected eyes, n 53
Range of VA at IRU presentation, n (%)
 6/6 to 6/12 34 (64.2 %)
 6/15 to 6/45 12 (22.6 %)
 6/60 or worse 7 (13.2 %)
Range of VA at 6-month follow-up post IRU diagnosis, n (%)
 6/6 to 6/12 35 (66.0 %)
 6/15 to 6/45 10 (18.9 %)
 6/60 or worse 8 (15.1 %)
VA change from IRU diagnosis to 6-month follow-up, n (%)
 Worsen by at least 3 lines 6 (11.3 %)
 Worsen by 2 lines 2 (3.8 %)
 Worsen by 1 line 6 (11.3 %)
 No change 18 (34.0 %)
 Improved by 1 line 7 (13.2 %)
 Improved by 2 lines 6 (11.3 %)
 Improved by at least 3 lines 8 (15.1 %)